Skip to main content

Table 2 Outcome of patients treated with BLICs or carbapenems

From: Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae

Outcomes BLICs Carbapenems Univariate analysis Multivariate analysis
N (%) Adjusted N (%) N (%) Adjusted N (%) P Adjusted P HR (95%CI), P Adjusted HR (95%CI), P
14-day treatment failure 25 (21.9) 13 (20.6) 17 (25.8) 7 (16.3) 0.970 0.429 1.61 (0.74–3.49), 0.230 2.19 (0.81–5.90), 0.122
30-day mortality 13 (11.4) 7 (11.1) 13 (19.7) 5 (11.6) 0.289 0.926 1.57 (0.62–4.01), 0.345 1.68 (0.48–5.93), 0.420